• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性5-羟色胺再摄取抑制剂对内分泌系统的影响(综述)

Effects of selective serotonin reuptake inhibitors on endocrine system (Review).

作者信息

Ruiz-Santiago Carolina, Rodríguez-Pinacho Carla Valeria, Pérez-Sánchez Gilberto, Acosta-Cruz Erika

机构信息

Department of Biotechnology, Faculty of Chemistry, Universidad Autónoma de Coahuila, Saltillo Coahuila 25280, México.

Laboratory of Psychoimmunology, National Institute of Psychiatry Ramón de la Fuente Muñíz, México City 14370, México.

出版信息

Biomed Rep. 2024 Jul 5;21(3):128. doi: 10.3892/br.2024.1816. eCollection 2024 Sep.

DOI:10.3892/br.2024.1816
PMID:39070109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273194/
Abstract

Selective serotonin reuptake inhibitors (SSRIs) are typically prescribed for treating major depressive disorder (MDD) due to their high efficacy. These drugs function by inhibiting the reuptake of serotonin [also termed 5-hydroxytryptamine (5-HT)], which raises the levels of 5-HT in the synaptic cleft, leading to prolonged activation of postsynaptic 5-HT receptors. Despite the therapeutic benefits of SSRIs, this mechanism of action also disturbs the neuroendocrine response. Hypothalamic-pituitary-adrenal (HPA) axis activity is strongly linked to both MDD and the response to antidepressants, owing to the intricate interplay within the serotonergic system, which regulates feeding, water intake, sexual drive, reproduction and circadian rhythms. The aim of the present review was to provide up-to-date evidence for the proposed effects of SSRIs, such as fluoxetine, citalopram, escitalopram, paroxetine, sertraline and fluvoxamine, on the endocrine system. For this purpose, the literature related to the effects of SSRIs on the endocrine system was searched using the PubMed database. According to the available literature, SSRIs may have an adverse effect on glucose metabolism, sexual function and fertility by dysregulating the function of the HPA axis, pancreas and gonads. Therefore, considering that SSRIs are often prescribed for extended periods, it is crucial to monitor the patient closely with particular attention to the function of the endocrine system.

摘要

选择性5-羟色胺再摄取抑制剂(SSRIs)因其高效性,通常被用于治疗重度抑郁症(MDD)。这些药物通过抑制5-羟色胺(也称为5-羟色氨酸,5-HT)的再摄取来发挥作用,从而提高突触间隙中5-HT的水平,导致突触后5-HT受体的持续激活。尽管SSRIs具有治疗作用,但其作用机制也会干扰神经内分泌反应。下丘脑-垂体-肾上腺(HPA)轴的活动与MDD以及对抗抑郁药的反应密切相关,这是由于5-羟色胺能系统内部存在复杂的相互作用,该系统调节进食、饮水、性欲、生殖和昼夜节律。本综述的目的是提供最新证据,证明氟西汀、西酞普兰、艾司西酞普兰、帕罗西汀、舍曲林和氟伏沙明等SSRIs对内分泌系统的影响。为此,使用PubMed数据库搜索了与SSRIs对内分泌系统影响相关的文献。根据现有文献,SSRIs可能通过调节HPA轴、胰腺和性腺的功能,对糖代谢、性功能和生育能力产生不利影响。因此,鉴于SSRIs通常需要长期服用,密切监测患者并特别关注内分泌系统的功能至关重要。

相似文献

1
Effects of selective serotonin reuptake inhibitors on endocrine system (Review).选择性5-羟色胺再摄取抑制剂对内分泌系统的影响(综述)
Biomed Rep. 2024 Jul 5;21(3):128. doi: 10.3892/br.2024.1816. eCollection 2024 Sep.
2
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.帕罗西汀:在治疗惊恐障碍中的药理学和治疗潜力的综述。
CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.
3
Clinical pharmacokinetics of selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的临床药代动力学
Clin Pharmacokinet. 1993 Mar;24(3):203-20. doi: 10.2165/00003088-199324030-00003.
4
Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的药代动力学-药效学关系
Clin Pharmacokinet. 1996 Dec;31(6):444-69. doi: 10.2165/00003088-199631060-00004.
5
Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.选择性5-羟色胺再摄取抑制剂的临床相关药理学。重点关注药代动力学及对药物氧化代谢影响的综述。
Clin Pharmacokinet. 1997;32 Suppl 1:1-21. doi: 10.2165/00003088-199700321-00003.
6
The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.六种最常用的选择性5-羟色胺再摄取抑制剂可降低H295R细胞系中的雄激素水平,并提高雌激素水平。
Toxicol In Vitro. 2017 Jun;41:1-11. doi: 10.1016/j.tiv.2017.02.001. Epub 2017 Feb 5.
7
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.选择性5-羟色胺再摄取抑制剂的比较药代动力学:镜后的审视
Int Clin Psychopharmacol. 1995 Mar;10 Suppl 1:15-21. doi: 10.1097/00004850-199503001-00004.
8
Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.选择性 5-羟色胺再摄取抑制剂:对眼压影响的综述。
Curr Neuropharmacol. 2008 Dec;6(4):293-310. doi: 10.2174/157015908787386104.
9
Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews.选择性 5-羟色胺再摄取抑制剂治疗重性抑郁障碍:系统评价的伞状综述。
Int J Psychiatry Clin Pract. 2020 Nov;24(4):357-370. doi: 10.1080/13651501.2020.1782433. Epub 2020 Jul 15.
10
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).选择性5-羟色胺再摄取抑制剂(SSRIs)的药理学特性
Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:19-26. doi: 10.1097/00004850-199403001-00004.

引用本文的文献

1
Impact of Chronic Fluoxetine Exposure on Oocyte Development and Reproductive Outcomes in a Mouse Model.慢性氟西汀暴露对小鼠模型中卵母细胞发育和生殖结局的影响
Int J Mol Sci. 2025 May 19;26(10):4858. doi: 10.3390/ijms26104858.
2
Reproductive Toxicity Induced by Serotonin-Norepinephrine Reuptake Inhibitors: A Pharmacovigilance Analysis From 2004 to 2023 Based on the FAERS Database.5-羟色胺-去甲肾上腺素再摄取抑制剂所致生殖毒性:基于FAERS数据库的2004年至2023年药物警戒分析
CNS Neurosci Ther. 2024 Dec;30(12):e70176. doi: 10.1111/cns.70176.
3
Vortioxetine as an alternative treatment for somatic symptom disorder: case report.伏硫西汀作为躯体症状障碍的替代治疗:病例报告。
Front Psychiatry. 2024 Nov 7;15:1496072. doi: 10.3389/fpsyt.2024.1496072. eCollection 2024.

本文引用的文献

1
Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss.抗抑郁药对胰高血糖素样肽-1受体激动剂相关体重减轻的影响。
J Pharm Technol. 2022 Oct;38(5):283-288. doi: 10.1177/87551225221110850. Epub 2022 Jul 29.
2
The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass.选择性 5-羟色胺再摄取抑制剂氟西汀对β细胞有直接作用,促进胰岛素分泌并增加β细胞量。
Diabetes Obes Metab. 2022 Oct;24(10):2038-2050. doi: 10.1111/dom.14791. Epub 2022 Jul 11.
3
Depression and Autoimmune Hypothyroidism-Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines-A Systematic Review.抑郁症与自身免疫性甲状腺功能减退症——它们的关系以及治疗精神疾病和甲状腺疾病对包括脑源性神经营养因子(BDNF)和其他细胞因子在内的临床和生化参数变化的影响——一项系统综述
Pharmaceuticals (Basel). 2022 Mar 24;15(4):391. doi: 10.3390/ph15040391.
4
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.选择性5-羟色胺再摄取抑制剂及其不良反应:一篇叙述性综述
Neurol Int. 2021 Aug 5;13(3):387-401. doi: 10.3390/neurolint13030038.
5
Leptin and Obesity: Role and Clinical Implication.瘦素与肥胖:作用与临床意义。
Front Endocrinol (Lausanne). 2021 May 18;12:585887. doi: 10.3389/fendo.2021.585887. eCollection 2021.
6
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19.氟伏沙明:作用机制及其在 COVID-19 中作用的综述
Front Pharmacol. 2021 Apr 20;12:652688. doi: 10.3389/fphar.2021.652688. eCollection 2021.
7
Effect of fluoxetine on the testes of adult albino rats and the possible protective role of curcumin.氟西汀对成年白化大鼠睾丸的影响及姜黄素的可能保护作用。
Anat Sci Int. 2021 Mar;96(2):187-196. doi: 10.1007/s12565-020-00573-9. Epub 2020 Oct 14.
8
Pharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis.焦虑症的药物治疗:下丘脑-垂体-肾上腺轴的作用
Front Psychiatry. 2020 May 15;11:443. doi: 10.3389/fpsyt.2020.00443. eCollection 2020.
9
Chronic exposure to paroxetine or bupropion modulates the pubertal maturation and the reproductive system in female rats.慢性暴露于帕罗西汀或安非他酮会调节雌性大鼠的青春期成熟和生殖系统。
Reprod Biol. 2020 Jun;20(2):154-163. doi: 10.1016/j.repbio.2020.03.009. Epub 2020 Apr 13.
10
Antidepressant-induced sexual dysfunction.抗抑郁药引起的性功能障碍。
Med J Aust. 2020 Apr;212(7):329-334. doi: 10.5694/mja2.50522. Epub 2020 Mar 15.